Efor among the leading consulting firms in Décideurs’ 2026 ranking
10/09/2026
We are proud to announce that Décideurs has once again ranked Efor among the leading consulting firms in France, with two distinctions in the healthcare and Life Sciences sector:
🥇 “Leading” in Regulatory Affairs
⭐ “Excellent” in Health Product Development & Commercialisation
Updated every year, the Décideurs rankings aim to identify leading firms across a range of areas of expertise.
This recognition reflects what sets Efor apart: our ability to turn regulatory complexity into a competitive advantage for our clients in the Life Sciences sector.
Expertise that goes beyond Regulatory Affairs
While mastering regulatory requirements is essential to the success of Life Sciences projects, at Efor it is part of a broader approach to quality, compliance and operational performance.
Quality & Compliance and CQV
Our experts support life sciences companies with their Commissioning, Qualification & Validation (CQV) challenges, helping ensure product quality and process control, from the laboratory through to large-scale manufacturing.
This approach is built on hands-on expertise and an in-depth understanding of the requirements specific to pharmaceutical and Life Sciences environments.
Project management and control of costs, timelines and risks
Efor also supports the management of complex programmes, from strategy definition through to transfer and facility readiness.
Our teams contribute to the management of large-scale CAPEX and OPEX programmes, with an integrated approach to cost, schedule and risk, helping secure the different stages of project execution.
Digital and AI supporting human expertise
Technological innovation is also part of our approach. Through our proprietary digital tools, we are exploring the potential of artificial intelligence to support teams, accelerate certain project activities and reduce rework.
The objective remains the same: augment human expertise and facilitate decision-making, while meeting the quality and compliance requirements specific to the Life Sciences sector.
An international presence, close to our clients
With a presence across several countries and locally based teams, Efor combines international expertise with on-the-ground proximity.
This organisation enables us to support our clients on international projects while taking into account the specific requirements of each market and environment.
Recognition of our expertise and commitment
These distinctions recognise our expertise in Regulatory Affairs and Health Product Development & Commercialisation.
Above all, they reflect the daily work of our teams alongside our clients and partners, helping deliver projects that are safer, more efficient and compliant with the requirements of the Life Sciences sector.
The result: faster validation, safer products and sustainable operational excellence for patients worldwide.
Thank you to our teams, clients and partners for their trust.
Thank you to Décideurs | Leaders League for this recognition. Discover the full rankings:
- Healthcare, Pharma & Biotechnology – Regulatory Affairs Consulting: https://www.leadersleague.com/fr/classements/sante-pharma-and-biotechnologies-conseils-en-affaires-reglementaires-cabinet-de-conseils-france-2026
- Healthcare, Pharma & Biotechnology – Health Product Development & Commercialisation (Pharma, Medical Devices): https://www.leadersleague.com/fr/classements/sante-pharma-and-biotechnologies-developpement-and-commercialisation-de-produits-de-sante-pharma-dm-cabinet-de-conseils-france-2026
Efor group
Our CSR commitments
Aware of our social and environmental responsibility, we act every day to make a positive impact on society.
Our news
Discover all our technical articles and news